The vaccine Development Pathway

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The decision to develop a vaccine is based on analysis of need and, in most cases, potential returns on the significant investment of time and resources required to move a candidate product from initial development through to licensure. The vaccine development pathway encompasses a series of highly regulated milestones designed to assess the safety and efficacy of a candidate vaccine via nonclinical testing, using animal models and in vitro assays, and in phased clinical trials in humans. Regulatory oversight also aims to ensure the consistency of its manufacture during the investigational phases and following its approval and licensure.

Original languageEnglish (US)
Title of host publicationVaccinology: An Essential Guide
PublisherWiley Blackwell
Pages33-42
Number of pages10
ISBN (Electronic)9781118638033
ISBN (Print)9780470656167
DOIs
StatePublished - Dec 9 2014

Fingerprint

Vaccines
Licensure
Animal Models
Clinical Trials
Safety
In Vitro Techniques

Keywords

  • Biologics license application
  • Clinical trials
  • Investigational new drug
  • National regulatory authority
  • Nonclinical testing

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Beasley, D. W. C. (2014). The vaccine Development Pathway. In Vaccinology: An Essential Guide (pp. 33-42). Wiley Blackwell. https://doi.org/10.1002/9781118638033.ch2

The vaccine Development Pathway. / Beasley, David W C.

Vaccinology: An Essential Guide. Wiley Blackwell, 2014. p. 33-42.

Research output: Chapter in Book/Report/Conference proceedingChapter

Beasley, DWC 2014, The vaccine Development Pathway. in Vaccinology: An Essential Guide. Wiley Blackwell, pp. 33-42. https://doi.org/10.1002/9781118638033.ch2
Beasley DWC. The vaccine Development Pathway. In Vaccinology: An Essential Guide. Wiley Blackwell. 2014. p. 33-42 https://doi.org/10.1002/9781118638033.ch2
Beasley, David W C. / The vaccine Development Pathway. Vaccinology: An Essential Guide. Wiley Blackwell, 2014. pp. 33-42
@inbook{77cb564a515b49928d1bd2aeb3086674,
title = "The vaccine Development Pathway",
abstract = "The decision to develop a vaccine is based on analysis of need and, in most cases, potential returns on the significant investment of time and resources required to move a candidate product from initial development through to licensure. The vaccine development pathway encompasses a series of highly regulated milestones designed to assess the safety and efficacy of a candidate vaccine via nonclinical testing, using animal models and in vitro assays, and in phased clinical trials in humans. Regulatory oversight also aims to ensure the consistency of its manufacture during the investigational phases and following its approval and licensure.",
keywords = "Biologics license application, Clinical trials, Investigational new drug, National regulatory authority, Nonclinical testing",
author = "Beasley, {David W C}",
year = "2014",
month = "12",
day = "9",
doi = "10.1002/9781118638033.ch2",
language = "English (US)",
isbn = "9780470656167",
pages = "33--42",
booktitle = "Vaccinology: An Essential Guide",
publisher = "Wiley Blackwell",

}

TY - CHAP

T1 - The vaccine Development Pathway

AU - Beasley, David W C

PY - 2014/12/9

Y1 - 2014/12/9

N2 - The decision to develop a vaccine is based on analysis of need and, in most cases, potential returns on the significant investment of time and resources required to move a candidate product from initial development through to licensure. The vaccine development pathway encompasses a series of highly regulated milestones designed to assess the safety and efficacy of a candidate vaccine via nonclinical testing, using animal models and in vitro assays, and in phased clinical trials in humans. Regulatory oversight also aims to ensure the consistency of its manufacture during the investigational phases and following its approval and licensure.

AB - The decision to develop a vaccine is based on analysis of need and, in most cases, potential returns on the significant investment of time and resources required to move a candidate product from initial development through to licensure. The vaccine development pathway encompasses a series of highly regulated milestones designed to assess the safety and efficacy of a candidate vaccine via nonclinical testing, using animal models and in vitro assays, and in phased clinical trials in humans. Regulatory oversight also aims to ensure the consistency of its manufacture during the investigational phases and following its approval and licensure.

KW - Biologics license application

KW - Clinical trials

KW - Investigational new drug

KW - National regulatory authority

KW - Nonclinical testing

UR - http://www.scopus.com/inward/record.url?scp=84976443371&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84976443371&partnerID=8YFLogxK

U2 - 10.1002/9781118638033.ch2

DO - 10.1002/9781118638033.ch2

M3 - Chapter

AN - SCOPUS:84976443371

SN - 9780470656167

SP - 33

EP - 42

BT - Vaccinology: An Essential Guide

PB - Wiley Blackwell

ER -